118 related articles for article (PubMed ID: 4018139)
1. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
3. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
List SJ; Wreggett KA; Seeman P
J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
[TBL] [Abstract][Full Text] [Related]
4. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
[TBL] [Abstract][Full Text] [Related]
5. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
6. Binding of [3H]ADTN to rat striatal membranes.
Templeton WW; Woodruff GN
Biochem Pharmacol; 1982 Apr; 31(8):1629-32. PubMed ID: 6124259
[TBL] [Abstract][Full Text] [Related]
7. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
8. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
9. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
[TBL] [Abstract][Full Text] [Related]
10. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
Hirschhorn ID; Makman MH
Eur J Pharmacol; 1982 Sep; 83(1-2):61-7. PubMed ID: 7128701
[TBL] [Abstract][Full Text] [Related]
11. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
[TBL] [Abstract][Full Text] [Related]
13. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
[TBL] [Abstract][Full Text] [Related]
14. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
Lamont JS; Kula NS; Baldessarini RJ
Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
16. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
Zahniser NR; Heidenreich KA; Molinoff PB
Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
[No Abstract] [Full Text] [Related]
17. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
18. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
[TBL] [Abstract][Full Text] [Related]
19. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
Osborne NN
Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
[TBL] [Abstract][Full Text] [Related]
20. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]